Abstract
Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 26-34 |
| Number of pages | 9 |
| Journal | Thorax |
| Volume | 71 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Cite this
International Committee on Mental Health in Cystic Fibrosis : Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. / Quittner, Alexandra; Abbott, Janice; Georgiopoulos, Anna M.; Goldbeck, Lutz; Smith, Beth; Hempstead, Sarah E.; Marshall, Bruce; Sabadosa, Kathryn A.; Elborn, Stuart; Boyle, Michael; Crossan, Amanda; Gartner, Silvia; Gerlach, Manfred; Rounds, Jennifer; Hug, Martin; Kvam, Christopher; Macias, Michelle; Mueller, Amy; Noordhoek, Jacquelien; Ramchandi, Paul; Reno, Kim; Riekert, Kristin; Uluer, Ahmet; Zirbes, Jacquelyn.
In: Thorax, Vol. 71, No. 1, 01.01.2016, p. 26-34.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - International Committee on Mental Health in Cystic Fibrosis
T2 - Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
AU - Quittner, Alexandra
AU - Abbott, Janice
AU - Georgiopoulos, Anna M.
AU - Goldbeck, Lutz
AU - Smith, Beth
AU - Hempstead, Sarah E.
AU - Marshall, Bruce
AU - Sabadosa, Kathryn A.
AU - Elborn, Stuart
AU - Boyle, Michael
AU - Crossan, Amanda
AU - Gartner, Silvia
AU - Gerlach, Manfred
AU - Rounds, Jennifer
AU - Hug, Martin
AU - Kvam, Christopher
AU - Macias, Michelle
AU - Mueller, Amy
AU - Noordhoek, Jacquelien
AU - Ramchandi, Paul
AU - Reno, Kim
AU - Riekert, Kristin
AU - Uluer, Ahmet
AU - Zirbes, Jacquelyn
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.
AB - Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.
UR - http://www.scopus.com/inward/record.url?scp=84958206254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958206254&partnerID=8YFLogxK
U2 - 10.1136/thoraxjnl-2015-207488
DO - 10.1136/thoraxjnl-2015-207488
M3 - Article
C2 - 26452630
AN - SCOPUS:84958206254
VL - 71
SP - 26
EP - 34
JO - Thorax
JF - Thorax
SN - 0040-6376
IS - 1
ER -